These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3035076)

  • 1. Serum and urine concentrations of oral bromovinyldeoxyuridine in humans as monitored by a bioassay system based on varicella-zoster virus focus inhibition.
    Baba M; Shigeta S; De Clercq E
    J Med Virol; 1987 May; 22(1):17-23. PubMed ID: 3035076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of various experimental conditions on the inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on varicella-zoster virus replication in cell culture.
    Baba M; Shigeta S; De Clercq E
    Tohoku J Exp Med; 1984 Aug; 143(4):441-9. PubMed ID: 6093286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    De Clercq E; Descamps J; Ogata M; Shigeta S
    Antimicrob Agents Chemother; 1982 Jan; 21(1):33-8. PubMed ID: 6282207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
    Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
    Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
    De Clercq E
    Med Res Rev; 2005 Jan; 25(1):1-20. PubMed ID: 15389733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.
    De Clercq E
    Biochem Pharmacol; 2004 Dec; 68(12):2301-15. PubMed ID: 15548377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiviral spectrum of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    De Clercq E
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():85-95. PubMed ID: 6092320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of bromovinyldeoxyuridine in anticancer chemotherapy.
    De Clercq E
    Anticancer Res; 1986; 6(4):549-56. PubMed ID: 3752935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.
    De C; Liu D; Zheng B; Singh US; Chavre S; White C; Arnold RD; Hagen FK; Chu CK; Moffat JF
    Antiviral Res; 2014 Oct; 110():10-9. PubMed ID: 25051026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis induced by (E)-5-(2-bromovinyl)-2'-deoxyuridine in varicella zoster virus thymidine kinase-expressing cells is driven by activation of c-Jun/activator protein-1 and Fas ligand/caspase-8.
    Tomicic MT; Friedrichs C; Christmann M; Wutzler P; Thust R; Kaina B
    Mol Pharmacol; 2003 Feb; 63(2):439-49. PubMed ID: 12527816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus.
    Shigeta S; Yokota T; Iwabuchi T; Baba M; Konno K; Ogata M; De Clercq E
    J Infect Dis; 1983 Mar; 147(3):576-84. PubMed ID: 6300257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acyclovir combined with other antiherpetic agents on varicella zoster virus in vitro.
    Biron KK; Elion GB
    Am J Med; 1982 Jul; 73(1A):54-7. PubMed ID: 6285733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
    Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
    Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides.
    Andrei G; Sienaert R; McGuigan C; De Clercq E; Balzarini J; Snoeck R
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1081-6. PubMed ID: 15728906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral bromovinyldeoxyuridine therapy for herpes simplex and varicella-zoster virus infections in severely immunosuppressed patients: a preliminary clinical trial.
    Tricot G; De Clercq E; Boogaerts MA; Verwilghen RL
    J Med Virol; 1986 Jan; 18(1):11-20. PubMed ID: 3511181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of (E)-5-(2-bromovinyl)-2'-deoxyuridine in plasma and urine by capillary electrophoresis.
    Olgemöller J; Hempel G; Boos J; Blaschke G
    J Chromatogr B Biomed Sci Appl; 1999 Apr; 726(1-2):261-8. PubMed ID: 10348194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.
    Maudgal PC; De Clercq E; Missotten L
    Antiviral Res; 1984 Oct; 4(5):281-91. PubMed ID: 6335020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mouse models for the investigation of experimental drugs with activity against human varicella-zoster virus.
    Weber O
    Antivir Chem Chemother; 2000 Jul; 11(4):283-90. PubMed ID: 10950390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of susceptibility of bicyclic nucleoside analogs, highly potent inhibitors of varicella-zoster virus, to the catabolic action of thymidine phosphorylase and dihydropyrimidine dehydrogenase.
    Balzarini J; Sienaert R; Liekens S; Van Kuilenburg A; Carangio A; Esnouf R; De Clercq E; McGuigan C
    Mol Pharmacol; 2002 May; 61(5):1140-5. PubMed ID: 11961132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of antiherpes drugs and drug resistant virus--effect of BVDU on varicella zoster virus replication].
    Shigeta S; Yokota T
    Rinsho Byori; 1985 Feb; 33(2):148-57. PubMed ID: 2987573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.